Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG(L)-scFv)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-128)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD64 antibody are fused to the C terminus of an anti-HER2 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG(L)-scFv) (IGLFV-128). Click the button below to contact us or submit your feedback about this product.